Biofrontera vs Sol-Gel Technologies
BFRI and SLGL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BFRI and SLGL compare
Sol-Gel Technologies grew revenue faster over the last twelve months (68.0% versus 29.8% for Biofrontera).
Biofrontera keeps more of each dollar of sales as profit, with a net margin of −12.7% compared with −31.6% at Sol-Gel Technologies.
Sol-Gel Technologies scores higher on the StockData Score (10 against 9 for Biofrontera), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BFRI | SLGL |
|---|---|---|
| Size and price | ||
| Market cap | $10.4M | – |
| Share price | $0.700 | $55.12 |
| Change, 1 year | −28.1% | 75.0% |
| Change, 5 years | −98.7% | −35.7% |
| Beta (5Y) | 0.97 | 1.00 |
| Employees | 92 | 28 |
| StockData Score | ||
| Total score | 9 | 10 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 2 | 3 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.2× | – |
| FCF yield | −53.4% | – |
| Growth | ||
| Revenue growth (TTM) | 29.8% | 68.0% (better) |
| Revenue growth, 5Y average | 17.2% (better) | 17.2% |
| Profitability | ||
| Operating margin | −14.1% (better) | −38.9% |
| Net margin | −12.7% (better) | −31.6% |
| FCF margin | −11.5% | 1.4% (better) |
| Return on equity | – | −15.3% |
| Return on invested capital | – | −153% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Current ratio | 0.78 | 10.37 (better) |
| Altman Z-score | −7.80 | – |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 18.6% | 47.5% |
| Held by insiders | 23.6% | 70.2% |
| Insider net buying, 12 months | – | $11.0M |
| Short interest, % of float | 1.7% | 16.3% |
Go deeper
- BFRI stock overview
- BFRI income statement
- BFRI valuation and score
- SLGL stock overview
- SLGL income statement
- SLGL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.